Company Update (NYSE:PFE): Pfizer Acquires Redvax GmbH

[Business Wire] – Pfizer Inc. today announced that it has acquired a controlling interest in Redvax GmbH, a spin-off from Redbiotec AG, a privately held Swiss biopharmaceutical company, based in Zurich-Schlieren. Read more . . . → Read More: Company Update (NYSE:PFE): Pfizer Acquires Redvax GmbH Similar Articles: Company Update (NYSE:PFE): Pfizer Declares First-Quarter 2015 Dividend Stock Update: Pfizer Inc (NYSE:PFE) – Pfizer and Breast Cancer Leaders Join Together to Increase Understanding and Dispel Myths about Metastatic Breast Cancer Company Update: Pfizer Inc (NYSE:PFE) – Pfizer Completes Acquisition Of InnoPharma